Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Uterine Cervical Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Adenomatous Polyposis Coli 2 Uterine Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Sezary Syndrome 1 Radiodermatitis 1 Prostate Cancer Metastatic Castration Resistant 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pain 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphoma, T-Cell, Cutaneous 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1 Gastritis, Atrophic 1 Fatigue 1 Endometrial Neoplasms 1 Communicable Diseases 1 Colorectal Neoplasms 1

Interventions

Cisplatin 130 Cetuximab 79 Radiotherapy 76 Docetaxel 58 Carboplatin 46 pembrolizumab 45 Paclitaxel 44 Fluorouracil 42 Radiotherapy, Intensity-Modulated 35 Drug Therapy 17 Radiation 14 Nivolumab 14 Gefitinib 14 Gemcitabine 13 Surgical Procedures, Operative 12 Oxaliplatin 11 Erlotinib Hydrochloride 11 Pemetrexed 10 Celecoxib 10 Capecitabine 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 10 tislelizumab 9 Filgrastim 9 Amifostine 9 Albumin-Bound Paclitaxel 9 durvalumab 7 atezolizumab 7 Chemoradiotherapy 7 toripalimab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Head and Neck Neoplasms × Curcumin × Clear all

NCT04208334 2023-03-28

CurChexia

Phramongkutklao College of Medicine and Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡